I’m including out-of-pocket and manpower costs for planning and conducting the trials, analyzing the results, and submitting applications for marketing in the US, EU, and other major jurisdictions (except Japan). I’m assuming the phase-3 DIC program will include at least two trials of 600+ patents each.